2/2
1. They are not really going to divulge any information of substance
2. They know approval is coming before July 3rd
3. Or, MHRA is not buying it and $NWBO is making a last ditch effort presenting its case to the world, thereby putting pressure on MHRA.
1/2 $NWBO A company that refuses to divulge even tiny bits of information is opening up a vital section of data that they have presented to MHRA, to the world? Especially when the MAA is still under review by MHRA? There could only be three possible reasons:
There are so many posts on what's going to happen to shorts/FUDs/MMs/Hedge funds, for more than a decade (without anything actually happening to them). It is like the whole point of $NWBO existence is to kill the shorts or smash the FUDs. NOT to get approval. What a travesty.
Leave alone Nasdaq or SOXX which are tech indices. Even IBB which is a Biotech index is surging to all time highs. You could have invested in the index and reaped ~20x returns as opposed to losing 99% with $NWBO. Without sacrificing the "helping the humanity" profile.
@neilmck37597308 What you call cult are just employees of PR firms that $NWBO employs. They have one job. To recruit new shareholders and to retain existing shareholders. To that effect they speak things as required by the narrative the management wishes to set at any given moment.
@BioPharmaMrkt@rjmsoflo Gene editing of Stem Cells is not any more complicated than Tylenol. Whereas DcVax-L is the most complex of all drugs ever sent for approval in the history of MHRA. Add to the complexity, the other drugs dont require any manufacturing approvals, only $NWBO does.
$NWBO in 6 years Elon musk increased his wealth by 3500%
The phenomenon is known as an OBWN
itโs a reverse NWBO, if you bought 6 years ago you would have lost the same
Playbook: get one set of posters to pump $nwbo to the sky - 60 to 90 days for approval. Get your options, bonus, additional shares etc. secured. Then after 900 days get another group of people (they may be the same set of people with a different ids) to preach patience.
@SouthernDrive21@visionNovastar Basically between how MHRA operates, and how $NWBO deliberately chose to pursue the application with MHRA (and not FDA) with full knowledge of how MHRA operates, all except LP, her cronies, and minions are ........ (fill in your expletive).
Here is a Biotech that moves its Primary/Study Completion Date ahead of schedule as opposed to $NWBO that has been moving it to future for God knows how long. Rightfully, the market associates a $7.5B Mkt Cap for one & $300M for other, for such execution. Nothing to do with MMs.
LP : BPs don't just bring a check book. They bring decades of result oriented execution expertise. Accepting that you are unable to get results is not defeat. Failure is, your ego not allowing you to accept it & you driving $NWBO to dust. Please sell. That'll be the best for all.
@SouthernDrive21 But $NWBO will not. They have quite obviously goofed up on something, as is their habit. But this time they cannot escape with excuses like "consultant on leave" or "we ran out of critical ingredient". So they will not admit anything and hide forever behind their "silence".
@SouthernDrive21 I see you are grasping for something to hold on to. My2c.
1. CHM meetings dont trigger RFIs
2. If you want to go by whats published it is 210 days clock-on for MHRA + 180/90/90 days max response time for RFI 1/2/3.
We are way past 570 days. It is upto $NWBO to PR whats going on.
What good is an update? Seriously! We don't want another breadcrumb thrown our way, like always. It is too late for all those shenanigans.
We want approval. Or we want change at the top. Or we want $NWBO sold to a BP.
Like right now.
Enough is enough.
LP: It is quite obvious that you are unable to get the approval. Please keep your greed and ego aside and move out. Bring in someone to handle professionally or sell $NWBO to the highest bidder. Too many lives on the line for your experimenting & learning of how to run a Biotech.
I can understand some calling out that families should not have to go overseas to access American innovation. What I cant understand is how they can tie that to MM's and lawsuits when $NWBO has not filed an application for approval in US but only chose to file overseas in UK.
An investment always has two legs - buying and selling. $NWBO is a rare kind. You only buy, can't sell. Only LP, her cronies, and her minions make money. All you get in return is a front row seat to hope, hype, and hollow promises. With a "believe in science" add on.
$NWBO they said under 20c was an opportunity in 2017. Ten years later they are saying the same thing. At least they are not saying different things at different times :-)